House conservatives and a coalition of 51 Republican senators are demanding the firing of top Food and Drug Administration officials who approved a new generic version of the abortion drug mifepristone.
The Republicans say the decision endangers women and undermines state laws protecting unborn children.
The push escalated after the FDA greenlit the generic on October 1 from Evita Solutions LLC, the third U.S. company authorized to produce the dangerous abortion drug, which now account for 63% of all abortions that kill babies.
Critics, including pro-life advocates and GOP lawmakers, argue the approval floods the market with a dangerous chemical that kills babies and exposes women to severe risks like hemorrhaging, infection and sepsis.
Please follow LifeNews.com on Gab for the latest pro-life news and info, free from social media censorship.
Rep. Mark Harris, a North Carolina Republican, led a group of House conservatives in a letter to Health and Human Services Secretary Robert F. Kennedy Jr., urging him to target specific FDA leaders in any upcoming layoffs.
“It is clear that rogue actors within the FDA are working to undermine both the sanctity of life and the Administration’s commitment to protecting it,” the lawmakers wrote. “For this reason, we respectfully urge that you consider the director of the Office of Generic Drugs, the director of the Center for Drug Evaluation and Research, and other bureaucrats responsible for this reckless decision as part of your reduction-in-force evaluations.”
The letter comes amid broader Republican frustration with the FDA’s handling of mifepristone, which blocks progesterone to starve babies to death and then followed by another drug that is misused to cause contractions and expel the baby’s body.
Pro-life groups say the Biden administration’s rollback of safeguards — including in-person doctor visits and follow-up care — has allowed mail-order distribution without verifying buyers or purposes, empowering abusers and traffickers.
Susan B. Anthony Pro-Life America President Marjorie Dannenfelser condemned the approval as “unconscionable,” saying in a statement: “This reckless decision by the FDA to expand the availability of abortion drugs is unconscionable. These dangerous drugs take the lives of unborn children, place women and underage girls at serious risk, empower abusers, and trample the pro-life laws enacted by states across the nation.”
Dannenfelser called for immediate reinstatement of Trump-era protections, including bans on mailing the pills.
Separately, 51 Republican senators — all but Sens. Lisa Murkowski of Alaska and Susan Collins of Maine — sent their own letter to Kennedy and FDA Commissioner Marty Makary, blasting the drug as “the biggest threat to unborn life in America today.”
The senators demanded suspension of the generic approval, inclusion of all versions in a safety review, and reinstatement of in-person dispensing requirements.
“Under current FDA regulations, these drugs can be obtained via mail order without meaningful consultation with a medical professional and without any confirmation of who is purchasing them or for what purpose,” the senators wrote. “These policies have enabled abortion pills to be obtained by abusers, traffickers, and even minors.”
The letter accused prior Democrat administrations of relying on “faulty data” to justify loosening rules, leading to higher complication rates than reported.
“Unrestricted access to abortion pills is systematically undermining states’ rights and violating pro-life state laws,” the senators said. “Every month, thousands of abortion drugs are shipped into states that have otherwise limited access to abortion after Dobbs, degrading pro-life laws at the state level across the country.”
Sen. Josh Hawley, R-Mo., who signed the letter, separately wrote to Makary demanding details on the approval process.
“This decision appears to ignore the science while advancing a highly questionable ideological agenda,” Hawley said.
He added on X: “FDA had promised to do a top-to-bottom safety review of the chemical abortion drug, but instead they’ve just greenlighted new versions of it for distribution. I have lost confidence in the leadership at FDA.”
The senators urged suspending distribution of mifepristone as an “imminent hazard” under federal law.
